September 5, 2024 by Stephanie Winn, UC Davis Credit: CC0 Public Domain An estimated one in eight men at some point will get prostate cancer. Those statistics are expected to surge in the next 15 years partly due to the Baby Boomer generation reaching the age when prostate cancer is most common. Millennials won’t be...
September 2, 2024 by Flinders University CDK9 is commonly over-expressed and amplified in prostate cancer. Credit: British Journal of Cancer (2024). DOI: 10.1038/s41416-024-02810-8Researchers from Flinders University and University of South Australia have unveiled a promising new strategy that could be used to treat the most aggressive forms of prostate cancer. Their study, published in British...
JULY 22, 2024 by Karolinska Institutet Credit: Karolina Grabowska from PexelsThe Stockholm3 blood test, developed by researchers at Karolinska Institutet, is equally effective at detecting prostate cancer in different ethnic groups, a new paper published in the Journal of Clinical Oncology reports. The test produces significantly better results than the current PSA standard. Stockholm3, a...
Researchers identified two risk factors that indicate higher risk of aggressive prostate cancer and could help minimize risk of death Peer-Reviewed PublicationMASS GENERAL BRIGHAM New research highlights the challenge of balancing the risks of overdiagnosing and underdiagnosing prostate cancer early enough to intervene and minimize risk of death. Recently, some experts have called for the...
By Paul McClureJuly 02, 2024 A novel combination treatment for advanced prostate cancer has been granted Fast Track status by the FDADepositphotos The US Food and Drug Administration (FDA) has green-lit the fast-tracking of an innovative personalized treatment for advanced prostate cancer following a promising clinical trial where the cancer disappeared completely in almost 40%...
NEWS RELEASE 3-JUN-2024 Peer-Reviewed PublicationUNIVERSITY OF EASTERN FINLAND Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. Published in Nucleic Acids Research, a recent study from the University of Eastern Finland Institute of Biomedicine suggests that the SIX2 protein may be a possible factor underlying increased plasticity...
Neil Skolnik, MD DISCLOSURES | May 22, 2024 I’m Dr Neil Skolnik, and today I’m going to talk about the American Urological Association’s (AUA’s) guideline on the early detection of prostate cancer. This guideline gives us the opportunity to revisit prostate cancer screening with prostate-specific antigen (PSA). Before I go over the recommendations, I want...
Men with mutations in a particular gene are at greater risk of developing metastases after prostate cancer.News Published: May 17, 2024 | Original story from Aarhus University Credit: iStock. Finding out that cancer has spread is always unwelcome news. A study from Aarhus University has identified a gene that determines whether patients with prostate cancer...
Howard Wolinsky In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate’s levels had jumped. Previously in a normal range, LaFrate’s PSA was now above 6 ng/mL, indicating an elevated likelihood for prostate cancer. The jazz guitarist from Leesburg, Florida, then 70 years old, underwent a biopsy, which found two Gleason 6 lesions....
by University of East Anglia Credit: Unsplash/CC0 Public DomainArtificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer that could revolutionize how the disease is diagnosed and treated in the future. The study published in Cell Genomics reveals that prostate cancer, which affects one in eight men in their lifetime, includes two different...
